Namzaric (Allergan, Inc.)
Welcome to the PulseAid listing for the Namzaric drug offered from Allergan, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Allergan, Inc. |
| NON-PROPRIETARY NAME: | memantine hydrochloride and donepezil hydrochloride |
| SUBSTANCE NAME: | |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | KIT |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2016-11-28 |
| END MARKETING DATE: | 0000-00-00 |
Namzaric HUMAN PRESCRIPTION DRUG Details:
| Item Description | Namzaric from Allergan, Inc. |
| LABELER NAME: | Allergan, Inc. |
| DEA SCHEDULE: | |
| ACTIVE STRENGTH: | () |
| START MARKETING DATE: | 2016-11-28 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0456-1229_d695cdc0-7d22-4eb1-947e-c7c4005473e7 |
| PRODUCT NDC: | 0456-1229 |
| APPLICATION NUMBER: | NDA206439 |